Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy. (Q43223973)
Jump to navigation
Jump to search
scientific article published on 18 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy. |
scientific article published on 18 January 2010 |
Statements
Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy (English)
Pavel Nemec
Henrieta Greslikova
Hana Filkova
Jana Tajtlova
Dana Kralova
Renata Kupska
Jan Smetana
Marta Krejci
Ludek Pour
Lenka Zahradova
Viera Sandecka
Zdenek Adam
Evzen Gregora
18 January 2010